One in five expressions of interest in UK regulator's pilot ...
The MHRA, will be running five pilot dialogues as part of its first year exploring a real-world evidence scientific dialogue programme.
Balancing efficiency with risks: How biopharma companies can...
AI technologies can enable companies to program, rather than write, submissions to health authorities.
Why security-first design is the fix to stalling AI pilot to...
For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.
Asking the right questions around AI, with Brian Alexander, ...
At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Welcome to the 7th Exosome-Based Therapeutic Development Sum...
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
Welcome to the 10th CDD for Biologics Summit
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
The Inaugural Multi-Omics Based Drug Discovery & Development
The Industry-Led Forum Dedicated to Expanding the Applications of Multi-Omics Across Therapeutic Development
2nd Translational Digital Pathology & AI Summit
Don’t miss the return of this event, uniting 60+ leading biopharma pioneers driving the adoption and utilization of digital pathology
The Obesity Drug Development Summit has landed in Europe!
The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this movement.